I see growth as a system.

My career started in industrial engineering at Harley-Davidson, where the job was to improve business performance across people, process and technology. Sometimes that meant more revenue. Sometimes better quality. Sometimes removing friction or redesigning a process.

That way of thinking still shapes how I approach growth: find the constraint, understand how the pieces interact, and improve the part that will create the greatest impact. Because growth rarely lives in one department.

At Sara Lee I led the launch of Hearty Slices, aligning product, pricing, retailer sell-in, sales, supply chain, agencies and consumer activation around one commercial plan. It delivered $52MM in first-year revenue, with 87% of volume incremental to the category.

A launch is not a campaign. It is a commercial system.

The proof threshold is higher, the buying cycle is longer, and the value story has to work clinically, operationally and financially.

My career has taken me from health system C-suites, to physician owners and founders, to consumers choosing in seconds at a shelf. The breadth is the point. An executive, a physician-owner and a shopper do not decide the same way. Using the same marketing playbook for all three means solving for the wrong decision.

But one principle stays the same across all three: commercialization succeeds or fails based on clarity and alignment.

Procedure volume was shifting into cash-constrained ambulatory surgery centers and the recommendation on the table was a 20% price cut. The disconnect was not our product, it was economic framing. Our equipment was already saving nursing time worth more than the premium we charged, and nobody had measured it. Capital grew 789% and consumables 43.2% year over year.

During that same period I was asked to get a sales talk track ready. My answer was that we were going to get a listening track first: insight before messaging, strategy before tactics. That contributed to my being promoted to lead a $250M business unit after eight months. Trust does not come from sounding certain. It comes from reducing uncertainty.

I launched a new brand into Costco after the opportunity had been dismissed internally as too complex. Large organizations move slowly because of ambiguity, so we removed it: a narrow scope, Costco-specific consumer research, internal support built early, and a risk-mitigated case rather than a pitch deck. The lesson was not to push harder or louder, but to structure the decision so clearly that it became easier to say yes.

Customers still asked whether Mayo Medical Laboratories was actually part of Mayo Clinic, but the name was the smallest part of it. We clarified our position against LabCorp and Quest, modernized digital ordering and the MarTech stack, and connected the brand promise to customer access, physician confidence and revenue conversion. Mayo Clinic already had the awareness. The goal was conversion. A rebrand without behavior change is expensive art.

The full stories, with the numbers, are on the Proof page, or hear them in my own words.

I do not begin by assuming you need more marketing. I ask what is actually constraining growth: demand, positioning, value communication, sales, customer experience, commercial readiness, process, team capability, technology, or the way those pieces fit together.

One of the first questions I ask is this. What buying behavior are we actually trying to change? A disappointing number tells you something is wrong. It does not tell you why. The goal is to reduce uncertainty, clarify what matters, and get growth moving.